Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Dan Bi An
Introduction
Dan Bi An is a notable inventor based in Yongin-si, South Korea. He has made significant strides in the field of pain management through his innovative research and development. His work focuses on the SCN9A gene, which plays a crucial role in pain perception.
Latest Patents
Dan Bi An holds a patent for an SCN9A antisense pain killer. This invention provides peptide nucleic acid derivatives that target the 3' splice site of exon 4 in the human SCN9A pre-mRNA. The peptide nucleic acid derivatives potently induce SCN9A mRNA splice variant(s) that lack the SCN9A exon 4 in cells. This innovation is useful for safely treating pains or conditions involving Na1.7 activity. He has 1 patent to his name.
Career Highlights
Dan Bi An is currently associated with Olipass Corporation, where he continues to advance his research in the field of biotechnology. His work has the potential to revolutionize pain management therapies and improve the quality of life for many individuals suffering from chronic pain.
Collaborations
Some of his coworkers include Shin Chung and Daram Jung, who contribute to the collaborative efforts at Olipass Corporation. Their combined expertise enhances the innovative environment within the company.
Conclusion
Dan Bi An's contributions to the field of pain management through his innovative patent demonstrate his commitment to advancing medical science. His work at Olipass Corporation is paving the way for new therapeutic options in pain treatment.